WO2010059742A1 - Traitement du cancer individualisé - Google Patents
Traitement du cancer individualisé Download PDFInfo
- Publication number
- WO2010059742A1 WO2010059742A1 PCT/US2009/065011 US2009065011W WO2010059742A1 WO 2010059742 A1 WO2010059742 A1 WO 2010059742A1 US 2009065011 W US2009065011 W US 2009065011W WO 2010059742 A1 WO2010059742 A1 WO 2010059742A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- genes
- cell
- cellular
- development
- cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Abstract
L'invention porte sur des procédés pour formuler des traitements pour des patients individuels atteints de cancer par l'évaluation de différences génomiques et/ou phénotypiques entre des tissus cancéreux et des tissus normaux et intégration des résultats pour identifier des voies dysfonctionnelles.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09759850A EP2366162A1 (fr) | 2008-11-18 | 2009-11-18 | Traitement du cancer individualisé |
IL212905A IL212905A0 (en) | 2008-11-18 | 2011-05-16 | Individualized cancer dignosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11589808P | 2008-11-18 | 2008-11-18 | |
US61/115,898 | 2008-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010059742A1 true WO2010059742A1 (fr) | 2010-05-27 |
Family
ID=41683176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/065011 WO2010059742A1 (fr) | 2008-11-18 | 2009-11-18 | Traitement du cancer individualisé |
Country Status (4)
Country | Link |
---|---|
US (1) | US10262103B2 (fr) |
EP (1) | EP2366162A1 (fr) |
IL (1) | IL212905A0 (fr) |
WO (1) | WO2010059742A1 (fr) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102183655A (zh) * | 2011-01-24 | 2011-09-14 | 中国人民解放军军事医学科学院生物医学分析中心 | 用于乳腺癌内分泌治疗预后判断的新的分子标志物cuedc2蛋白质 |
CN102269766A (zh) * | 2010-06-01 | 2011-12-07 | 北京大学 | 人类基因fam96a及其蛋白质的应用 |
US20120238464A1 (en) * | 2011-03-18 | 2012-09-20 | Baylor Research Institute | Biomarkers for Predicting the Recurrence of Colorectal Cancer Metastasis |
CN102772803A (zh) * | 2011-05-12 | 2012-11-14 | 北京大学 | Unc5cl及其编码蛋白的应用 |
US8426418B2 (en) | 2010-08-27 | 2013-04-23 | CollabRx Inc. | Method to treat melanoma in BRAF inhibitor-resistant subjects |
CN103146821A (zh) * | 2013-02-25 | 2013-06-12 | 安徽农业大学 | 一种snp位点对性状遗传效应的评价方法及应用 |
WO2017073971A1 (fr) * | 2015-10-28 | 2017-05-04 | 숙명여자대학교산학협력단 | Composition contenant un inhibiteur d'expression ou d'activation de protéine anks1a comme principe actif pour prévenir ou traiter un cancer et procédé de criblage pour la composition |
US9850543B2 (en) | 2013-03-15 | 2017-12-26 | Novartis Ag | Biomarkers associated with BRM inhibition |
CN108841960A (zh) * | 2018-07-12 | 2018-11-20 | 吉林大学 | 一种结肠腺癌易感性预测试剂盒及系统 |
CN112812179A (zh) * | 2021-01-19 | 2021-05-18 | 北京大学 | 高亲和力高特异性抗cmtm6单克隆抗体及其用途 |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9499864B2 (en) | 2003-11-03 | 2016-11-22 | Aab Patent Holding Aps | Expression of FABP4 and other genes associated with bladder cancer progression |
US8583380B2 (en) | 2008-09-05 | 2013-11-12 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
US20130143747A1 (en) * | 2011-12-05 | 2013-06-06 | Myriad Genetics, Incorporated | Methods of detecting cancer |
WO2011060080A2 (fr) * | 2009-11-10 | 2011-05-19 | Gema Diagnostics, Inc. | Gènes exprimés de façon différentielle par les cellules du cumulus et dosages les utilisant pour identifier des oocytes compétents pour une grossesse |
CA3007713C (fr) | 2010-04-29 | 2020-05-26 | The Regents Of The University Of California | Algorithme de reconnaissance de voie a l'aide d'integration de donnees sur des modeles genetiques (paradigme) |
US10192641B2 (en) | 2010-04-29 | 2019-01-29 | The Regents Of The University Of California | Method of generating a dynamic pathway map |
US20130116150A1 (en) | 2010-07-09 | 2013-05-09 | Somalogic, Inc. | Lung Cancer Biomarkers and Uses Thereof |
SG2014007454A (en) | 2010-08-13 | 2014-07-30 | Somalogic Inc | Pancreatic cancer biomarkers and uses thereof |
US9309556B2 (en) | 2010-09-24 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
AU2011312491B2 (en) * | 2010-09-27 | 2015-06-04 | Somalogic, Inc. | Mesothelioma biomarkers and uses thereof |
NZ589251A (en) | 2010-11-12 | 2014-07-25 | Pacific Edge Ltd | Novel marker for detection of bladder cancer |
KR101371697B1 (ko) * | 2011-02-07 | 2014-03-07 | 연세대학교 원주산학협력단 | 환자 맞춤형 암 치료 |
WO2012174378A2 (fr) | 2011-06-17 | 2012-12-20 | Myriad Genetics, Inc. | Méthodes et matériaux permettant de déterminer un déséquilibre allélique |
SG2014012728A (en) | 2011-08-23 | 2014-06-27 | Foundation Medicine Inc | Novel kif5b-ret fusion molecules and uses thereof |
WO2013055911A1 (fr) | 2011-10-14 | 2013-04-18 | Dana-Farber Cancer Institute, Inc. | Biomarqueur znf365/zfp365 pouvant prévoir une réponse anticancéreuse |
US20130144584A1 (en) * | 2011-12-03 | 2013-06-06 | Medeolinx, LLC | Network modeling for drug toxicity prediction |
WO2013132440A1 (fr) * | 2012-03-07 | 2013-09-12 | Manuel Gidekel | Biomarqueurs tumoraux destinés au cancer du pancréas |
EP2861766B1 (fr) * | 2012-06-13 | 2018-08-08 | King Abdullah University Of Science And Technology | Biomarqueurs de méthylation pour le cancer du sein |
WO2014038884A1 (fr) * | 2012-09-07 | 2014-03-13 | 주식회사 마크로젠 | Protéine de fusion et composition pour diagnostiquer le cancer la comprenant |
WO2014043628A1 (fr) * | 2012-09-14 | 2014-03-20 | Memorial Sloan-Kettering Cancer Center | Gènes associés à une sensibilité au dasatinib |
WO2014071316A1 (fr) * | 2012-11-02 | 2014-05-08 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Identification in silico de voies de signalisation moléculaires liées au cancer et médicaments candidats |
WO2014113204A1 (fr) | 2013-01-17 | 2014-07-24 | Personalis, Inc. | Procédés et systèmes d'analyse génétique |
WO2014152377A1 (fr) * | 2013-03-14 | 2014-09-25 | Vanderbilt University | Méthodes de classement et de traitement des adénocarcinomes |
EP2971129B1 (fr) | 2013-03-15 | 2018-05-09 | Sutter Bay Hospitals | Antigène falz destiné a être utilisé comme cible pour thérapies destinées à traiter le cancer |
US10968484B2 (en) | 2013-03-15 | 2021-04-06 | The Broad Institute, Inc. | Methods of identifying responses to map kinase inhibition therapy |
RU2528247C2 (ru) * | 2013-05-07 | 2014-09-10 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Способ оценки чувствительности клеток рака легкого к доксорубицину на основании уровней экспрессии маркерных генов и набор для его осуществления |
WO2014189832A1 (fr) * | 2013-05-22 | 2014-11-27 | Albert Einstein College Of Medicine Of Yeshiva University | Dosages du récepteur de l'il-34 et utilisations associées |
DK3039424T3 (da) * | 2013-08-28 | 2020-08-31 | Crown Bioscience Inc Taicang | Genekspressionssignaturer, der er prædiktive for et individs respons på en multikinaseinhibitor, og fremgangsmåder til anvendelse af disse |
EP3965111A1 (fr) | 2013-08-30 | 2022-03-09 | Personalis, Inc. | Méthodes et systèmes d'analyse génomique |
CN103525916B (zh) * | 2013-09-24 | 2016-06-15 | 浙江大学医学院附属第四医院 | 评估肝细胞癌预后的试剂盒及rffl的应用 |
GB2535066A (en) | 2013-10-03 | 2016-08-10 | Personalis Inc | Methods for analyzing genotypes |
WO2015061348A1 (fr) * | 2013-10-21 | 2015-04-30 | Memorial Sloan-Kettering Cancer Center | L'atrx comme diagnostic compagnon pour des inhibiteurs de cdk4 |
US20170002421A1 (en) * | 2013-12-23 | 2017-01-05 | The General Hospital Corporation | Methods and assays for determining reduced brca1 pathway function in a cancer cell |
US20170003292A1 (en) * | 2014-03-13 | 2017-01-05 | H. Lee Moffitt Cancer Center And Research Institut Inc. | Paxip1 as a biomarker for wee1 inhibitor therapy |
US20150269307A1 (en) * | 2014-03-18 | 2015-09-24 | Texas Tech University System | Target inhibition map system for combination therapy design and methods of using same |
CN103969452B (zh) * | 2014-05-30 | 2016-04-20 | 中国人民解放军第二军医大学 | 索拉菲尼个性化治疗肝癌的分型诊断试剂盒 |
CN106415560A (zh) * | 2014-06-25 | 2017-02-15 | 皇家飞利浦有限公司 | 辅助患者和临床医师使用共享并且以患者为中心的决策支持工具的系统和方法 |
US20170283882A1 (en) * | 2014-09-05 | 2017-10-05 | Duke University | Methods and therapeutics relating to mrna biomarkers for clinical prognosis of cancer |
WO2016070131A1 (fr) | 2014-10-30 | 2016-05-06 | Personalis, Inc. | Procédés d'utilisation du mosaïcisme dans des acides nucléiques prélevés de façon distale par rapport à leur origine |
MA48487B1 (fr) * | 2014-12-23 | 2021-11-30 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers |
JP2018523823A (ja) * | 2015-08-04 | 2018-08-23 | セルジーン コーポレイション | 慢性リンパ球性白血病の治療方法及び免疫調節療法に対する臨床的感度の予測因子としてのバイオマーカーの利用 |
US10720227B2 (en) | 2015-08-12 | 2020-07-21 | Samsung Electronics Co., Ltd. | Method and device for mutation prioritization for personalized therapy |
CN105483226B (zh) * | 2015-12-21 | 2018-06-19 | 中国人民解放军第三军医大学第三附属医院 | 一种检测strap基因转录水平的方法及试剂盒 |
US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
CN110234769A (zh) * | 2016-12-01 | 2019-09-13 | 牛津生物动力有限公司 | 表观遗传染色体相互作用在癌症诊断中的应用 |
EP3568864A1 (fr) * | 2017-01-11 | 2019-11-20 | Koninklijke Philips N.V. | Procédé et système de détection automatisée de critères d'inclusion ou d'exclusion |
CN106729756B (zh) * | 2017-02-28 | 2021-05-25 | 青岛泱深生物医药有限公司 | 生物标志物作为靶标在肺腺癌诊治中的应用 |
CN108732349A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Lta4h作为指示肝内结节及早期预警肝癌的生物标志物 |
CN108732350A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Pla2g6作为指示肝内结节及早期预警肝癌的生物标志物 |
CN108732351A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Eps8l2作为指示肝内结节及早期预警肝癌的生物标志物 |
CN107881231A (zh) * | 2017-10-18 | 2018-04-06 | 中国人民解放军兰州军区兰州总医院 | Lmo3基因在制备胶质瘤抗肿瘤药物中的应用 |
US20190249229A1 (en) * | 2018-02-12 | 2019-08-15 | Nant Holdings Ip, Llc | Bam signatures from liquid and solid tumors and uses therefor |
US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US20210308171A1 (en) * | 2018-08-07 | 2021-10-07 | The Broad Institute, Inc. | Methods for combinatorial screening and use of therapeutic targets thereof |
CN110343759A (zh) * | 2019-06-03 | 2019-10-18 | 张鹏 | Trpv4的用途及其抑制剂的用途和药物筛选方法 |
CN110423812B (zh) * | 2019-07-02 | 2023-07-25 | 南方医科大学 | Skiv2l2(MTR4)基因在肿瘤治疗中的用途 |
CN110687284B (zh) * | 2019-08-26 | 2023-05-23 | 中国医学科学院肿瘤医院 | 检测血清中six2自身抗体的试剂的应用 |
CN110687283B (zh) * | 2019-08-26 | 2023-05-23 | 中国医学科学院肿瘤医院 | 自身抗体在诊断和/或治疗肿瘤中的应用 |
CN110596403B (zh) * | 2019-09-17 | 2022-12-16 | 中山大学附属第一医院 | 用于卵巢癌诊断的特异性蛋白标记物及制备方法 |
WO2021155192A1 (fr) * | 2020-01-30 | 2021-08-05 | Thomas Jefferson University | Compositions et méthodes d'utilisation de colorants cyanine pour cibler le cancer et les mitochondries |
CN114277137B (zh) * | 2020-03-30 | 2022-09-02 | 中国医学科学院肿瘤医院 | 外泌体arpc5、hmgn1等在肺癌诊断中的应用 |
IT202000028628A1 (it) * | 2020-11-26 | 2022-05-26 | Ceinge Biotecnologie Avanzate S C A R L | Metodo per prevedere la formazione di metastasi in pazienti tumorali |
KR102505355B1 (ko) * | 2021-04-16 | 2023-03-02 | 울산과학기술원 | Thrap3 및 ddx5의 결합을 이용한 암 치료제 스크리닝 방법 |
CN113652486B (zh) * | 2021-09-13 | 2023-02-03 | 新疆医科大学第四附属医院 | 结直肠癌治疗预后生物标志物及其应用 |
CN114277136B (zh) * | 2021-12-07 | 2023-09-22 | 武汉瑟文生物科技有限公司 | 一种基于ecDNA上的肺癌基因标志物及其应用 |
US20240095273A1 (en) * | 2022-09-16 | 2024-03-21 | Google Llc | Actionable suggestions for media content |
CN116482367A (zh) * | 2023-05-04 | 2023-07-25 | 中国中医科学院望京医院(中国中医科学院骨伤科研究所) | 一种联合mSEPT9检测和生物标志物的结直肠癌检测方法 |
CN117192127A (zh) * | 2023-08-18 | 2023-12-08 | 肇庆医学高等专科学校 | 一种hcc治疗靶点的发现方法 |
CN117305452B (zh) * | 2023-09-27 | 2024-05-03 | 山东大学第二医院 | 人SNRK mRNA在非小细胞肺癌诊断、靶向治疗和预后评估中的应用及试剂盒 |
CN117567651B (zh) * | 2024-01-15 | 2024-03-26 | 中国人民解放军东部战区总医院 | 协同表达血管内皮黏附分子vcam1的嵌合抗原受体及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040197774A1 (en) * | 1992-11-12 | 2004-10-07 | Michael Wigler | Representational approach to DNA analysis |
US5436142A (en) * | 1992-11-12 | 1995-07-25 | Cold Spring Harbor Laboratory | Methods for producing probes capable of distingushing variant genomic sequences |
US20030224464A1 (en) * | 2002-01-31 | 2003-12-04 | Baylor College Of Medicine | Secreted caveolin as a marker for prostate cancer |
US20070172844A1 (en) * | 2005-09-28 | 2007-07-26 | University Of South Florida | Individualized cancer treatments |
-
2009
- 2009-11-18 EP EP09759850A patent/EP2366162A1/fr not_active Withdrawn
- 2009-11-18 WO PCT/US2009/065011 patent/WO2010059742A1/fr active Application Filing
- 2009-11-18 US US12/621,408 patent/US10262103B2/en active Active
-
2011
- 2011-05-16 IL IL212905A patent/IL212905A0/en unknown
Non-Patent Citations (2)
Title |
---|
BARRA ET AL: "Robust segmentation and analysis of DNA microarray spots using an adaptative split and merge algorithm", COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, ELSEVIER, AMSTERDAM, NL, vol. 81, no. 2, 1 February 2006 (2006-02-01), pages 174 - 180, XP024895754, ISSN: 0169-2607, [retrieved on 20060201] * |
WULFKUHLE J ET AL: "Genomic and proteomic technologies for individualisation and improvement of cancer treatment", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 40, no. 17, 1 November 2004 (2004-11-01), pages 2623 - 2632, XP004646472, ISSN: 0959-8049 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102269766A (zh) * | 2010-06-01 | 2011-12-07 | 北京大学 | 人类基因fam96a及其蛋白质的应用 |
CN102269766B (zh) * | 2010-06-01 | 2015-08-26 | 北京大学 | 人类基因fam96a及其蛋白质的应用 |
US8426418B2 (en) | 2010-08-27 | 2013-04-23 | CollabRx Inc. | Method to treat melanoma in BRAF inhibitor-resistant subjects |
CN102183655A (zh) * | 2011-01-24 | 2011-09-14 | 中国人民解放军军事医学科学院生物医学分析中心 | 用于乳腺癌内分泌治疗预后判断的新的分子标志物cuedc2蛋白质 |
US20120238464A1 (en) * | 2011-03-18 | 2012-09-20 | Baylor Research Institute | Biomarkers for Predicting the Recurrence of Colorectal Cancer Metastasis |
CN102772803A (zh) * | 2011-05-12 | 2012-11-14 | 北京大学 | Unc5cl及其编码蛋白的应用 |
CN103146821B (zh) * | 2013-02-25 | 2015-06-17 | 安徽农业大学 | 一种snp位点对性状遗传效应的评价方法及应用 |
CN103146821A (zh) * | 2013-02-25 | 2013-06-12 | 安徽农业大学 | 一种snp位点对性状遗传效应的评价方法及应用 |
US9850543B2 (en) | 2013-03-15 | 2017-12-26 | Novartis Ag | Biomarkers associated with BRM inhibition |
WO2017073971A1 (fr) * | 2015-10-28 | 2017-05-04 | 숙명여자대학교산학협력단 | Composition contenant un inhibiteur d'expression ou d'activation de protéine anks1a comme principe actif pour prévenir ou traiter un cancer et procédé de criblage pour la composition |
CN108841960A (zh) * | 2018-07-12 | 2018-11-20 | 吉林大学 | 一种结肠腺癌易感性预测试剂盒及系统 |
CN108841960B (zh) * | 2018-07-12 | 2022-02-01 | 吉林大学 | 一种结肠腺癌易感性预测试剂盒及系统 |
CN112812179A (zh) * | 2021-01-19 | 2021-05-18 | 北京大学 | 高亲和力高特异性抗cmtm6单克隆抗体及其用途 |
CN112812179B (zh) * | 2021-01-19 | 2022-07-22 | 北京大学 | 高亲和力高特异性抗cmtm6单克隆抗体及其用途 |
Also Published As
Publication number | Publication date |
---|---|
US20100130527A1 (en) | 2010-05-27 |
EP2366162A1 (fr) | 2011-09-21 |
US10262103B2 (en) | 2019-04-16 |
IL212905A0 (en) | 2011-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10262103B2 (en) | Individualized cancer treatment | |
US20210104321A1 (en) | Machine learning disease prediction and treatment prioritization | |
US10870888B2 (en) | Methods and systems for analysis of organ transplantation | |
US20240102095A1 (en) | Methods for profiling and quantitating cell-free rna | |
US11401552B2 (en) | Methods of identifying male fertility status and embryo quality | |
CN110499364A (zh) | 一种用于检测扩展型遗传病全外显子的探针组及其试剂盒和应用 | |
US11610646B2 (en) | Methods, systems and processes of identifying genetic variation in highly similar genes | |
WO2019079647A2 (fr) | Ia statistique destinée à l'apprentissage profond et à la programmation probabiliste, avancés, dans les biosciences | |
WO2016004387A1 (fr) | Signature d'expression génique utilisable à des fins de pronostic du cancer | |
WO2008086182A2 (fr) | Utilisation de signatures de gène pour concevoir de nouveaux régimes de traitement de cancer | |
WO2012031008A2 (fr) | Matières biologiques liées au cancer dans des microvésicules | |
AU2010326066A1 (en) | Classification of cancers | |
WO2019008412A1 (fr) | Utilisation d'une analyse d'expression génique fondée sur le sang pour la prise en charge du cancer | |
CN103890193A (zh) | 用于确定吸烟状态的方法和组合物 | |
WO2019008415A1 (fr) | Analyse d'expression génique à base d'exosomes et de pbmc pour la prise en charge du cancer | |
WO2019008414A1 (fr) | Analyse d'expression génique fondée sur des exosomes pour la prise en charge du cancer | |
KR20200044677A (ko) | 암 약물 반응성 판단을 위한 바이오 마커, 이를 이용한 암 약물 반응성 판단 방법 및 이를 위한 암 약물 반응성 진단칩 | |
CA3178405A1 (fr) | Procedes et systemes d'analyse par apprentissage machine de polymorphismes mononucleotidiques dans le lupus | |
WO2014162008A2 (fr) | Nouvelle signature de biomarqueur et ses utilisations | |
WO2023091587A1 (fr) | Systèmes et procédés pour le ciblage de thérapies contre la covid-19 | |
US20230220470A1 (en) | Methods and systems for analyzing targetable pathologic processes in covid-19 via gene expression analysis | |
KR20200044682A (ko) | Igfr 약물 반응성 판단을 위한 바이오 마커 조성물, 바이오 마커 조성물을 이용한 igfr 약물 반응성 판단 방법 및 igfr 약물 반응성 판단을 위한 바이오 마커 조성물 검출용 진단칩 | |
Wong et al. | Evolution of network biomarkers from early to late stage bladder cancer samples | |
US20210193267A1 (en) | Methods, systems, and related computer program products for evaluating cancer model fidelity | |
Almeida | Molecular diagnosis of autism spectrum disorder through whole exome sequencing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09759850 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 212905 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4676/DELNP/2011 Country of ref document: IN Ref document number: 2009759850 Country of ref document: EP |